About Wyeth

Outstanding Global Brands, Exciting New Products and a Rich Research Pipeline

Wyeth improves the lives of millions of people around the world with its outstanding products. And new, innovative medicines are on the way. With research and development (R&D) programs focused on small molecules, vaccines and biotechnology, Wyeth is exploring more than 60 new therapies for medical conditions such as diabetes, breast cancer, multiple sclerosis, HIV, Alzheimer’s disease and schizophrenia.

Wyeth Pharmaceuticals

Wyeth has a long history of pioneering developments in pharmaceuticals and biotechnology, with leading products in the areas of women’s health care, neuroscience, musculoskeletal disorders, cardiovascular therapy, vaccines and infectious disease, hemophilia, immunology and oncology. Wyeth also is a leader in the development of nutritionals.

Women’s Health Care

For more than 60 years, Wyeth has been the leader in women’s health care with its postmenopausal hormone therapies and oral contraceptives. Wyeth is committed to developing new therapies with the potential to significantly improve the health of women worldwide. To achieve this goal, Wyeth formed the Women’s Health Research Institute^® — the first institute in the pharmaceutical industry dedicated solely to research in women’s health. After several years of research, Wyeth introduced new low doses of its postmenopausal hormone therapy products. Research currently is underway on several other products intended to improve the quality of women’s lives.

Neuroscience

Wyeth’s global neuroscience efforts have produced a novel therapy for depression and for the treatment of generalized anxiety disorder. Working with three discovery platforms — small molecules, vaccines and biotechnology — Wyeth researchers continue to develop treatments targeted for a wide range of central nervous system disabilities, such as multiple sclerosis, Alzheimer’s disease, depression, anxiety and schizophrenia.

Vaccines and Infectious Disease

Wyeth’s vaccines and infectious disease franchises share a common mission: to reduce the number of serious illnesses and deaths from bacterial and viral infections and to address the growing problem of bacterial resistance to existing treatments. In recent years, Wyeth has developed some of the most innovative vaccines in the health care arena. Our R&D focuses on producing vaccines for infants and children around the world. We are proud of the impact Wyeth has had on children’s lives, and we are dedicated to continually developing vaccines so children can have a healthier future.

Musculoskeletal Disorders

Wyeth’s musculoskeletal disorders franchise develops important new therapies for patients with joint and bone disease. Our products include treatments for rheumatoid arthritis that help patients lead more active lives. In addition, Wyeth has a strong presence in the osteoarthritis treatment market. In research, Wyeth scientists are investigating novel treatments for bone and tissue repair.

Internal Medicine

Our broad and expanding internal medicine franchise includes cardiovascular and gastrointestinal products. Wyeth’s internal medicine researchers are exploring novel approaches to treat diabetes, heart conditions and vascular disorders.

Hemophilia Treatment

Since the 1980s, Wyeth has been a global leader in the search for safer and more effective treatments for hemophilia A and B. As a result of this commitment and a significant investment in recombinant DNA technology, our efforts have led to important medical advances in the treatment of these potentially debilitating diseases.

Immunology and Oncology

Wyeth’s work in immunology focuses on producing novel immunosuppressants for organ transplantation. Our efforts in oncology include chemotherapy agents for acute myeloid leukemia and a platelet growth promoter to help patients after chemotherapy. Wyeth currently has several promising oncology therapies in clinical trials, including treatments for renal cell carcinoma, breast cancer and mantle cell lymphoma.

Wyeth Consumer Healthcare

Wyeth Consumer Healthcare is built on strong global brands, including some of the world’s most popular and best-known consumer health care products. Three of our well-established product lines — Advil^®, Centrum^® and Robitussin^® — are among the top 20 non-prescription medicines in the world. Other key brands include ChapStick^®, the Caltrate^® family of calcium supplements, Alavert^®, Preparation H^® and Dimetapp^®.

Fort Dodge Animal Health

As a world leader in animal health, Fort Dodge Animal Health offers a broad range of biological and pharmaceutical products for the companion animal, equine, livestock, swine and poultry industries. Innovative Fort Dodge products include West Nile-Innovator^®, Duramune^® Adult, CYDECTIN^® Pour-on, the Pyramid^® vaccine line, Quest^® Gel and EtoGesic^® Tablets.

118935-00